AI Customer Research for Pharma & Life Sciences

The Bottom Line

Pharma and life sciences teams need qualitative depth — why a physician prescribes one therapy over another, how a patient experiences a treatment journey, what a payer values in a formulary decision — but traditional market research in this industry is slow and expensive, often taking weeks to recruit and field, with moderator costs that limit sample size. Koji lets pharma, biotech, and medical device teams run AI-moderated voice and text interviews that field in days instead of weeks, probe every answer automatically, and produce analysis-ready reports — while you keep tight control over what data is collected. The result is roughly 10x faster time-to-insight than manual moderated research, at a fraction of the cost per conversation.

This guide covers where AI interviews fit in pharma research, how to design compliant studies, and the specific Koji capabilities that make it work.

Where AI interviews fit in life sciences research

Life sciences research spans a wide set of audiences and decisions. AI-moderated interviews are a strong fit wherever you need structured qualitative depth at scale:

• HCP insights: understand prescribing rationale, unmet clinical needs, treatment switching triggers, and reactions to new data or indications.
• Patient journey research: map diagnosis-to-treatment journeys, adherence barriers, and quality-of-life impacts in the patient's own words.
• Message and concept testing: test non-promotional educational concepts, positioning, and value propositions before committing budget.
• Market access and payer research: explore how decision-makers weigh evidence, cost, and outcomes.
• Medical device usability and adoption: capture how clinicians and patients actually use a device and where friction lives.
• Patient advisory and voice-of-patient programs: run always-on listening that scales beyond a handful of advisory board members.

In each case, the qualitative why is what drives the decision — and that is exactly what surveys miss and what AI interviews capture.

Why traditional pharma research falls short

The classic approaches each carry a tax:

• Moderated interviews and focus groups deliver depth but cost thousands per session and take weeks to schedule across busy clinicians.
• Surveys scale and field fast, but force respondents into pre-written boxes and never ask the obvious follow-up. You learn what but rarely why.
• Advisory boards give you deep relationships with a few experts, but the sample is tiny and the cadence is occasional.

The gap is a method that combines the depth of an interview with the scale and speed of a survey. That is the category Koji is built for.

How Koji works for life sciences teams

AI-moderated voice and text interviews. You write a research brief, and Koji's AI conducts the interview — asking your questions and generating intelligent follow-ups in real time. An HCP can complete a voice interview from their phone between patients; a patient can respond by text on their own schedule. No moderator to book, no calendar Tetris.

Automatic follow-up probing. When a respondent gives a thin answer — "I switched because of side effects" — Koji probes: which side effects, how severe, what would have changed the decision. This is the laddering a skilled human moderator does, applied consistently across every interview.

Structured questions for mixed-methods rigor. Koji supports six structured question types — open_ended, scale, single_choice, multiple_choice, ranking, and yes_no — so you can capture a clean satisfaction or likelihood-to-prescribe scale alongside rich open-ended narrative in the same interview. Reports visualize scales as distributions and choices as frequency charts, giving you quant and qual in one study. See the structured questions guide for details.

Real-time, analysis-ready reports. As interviews come in, Koji synthesizes themes, surfaces representative verbatim quotes, and quantifies structured responses — so you are reading insights, not transcribing recordings.

Quality gate. Only conversations that score 3 or higher on Koji's quality scale count toward your plan, which protects against low-effort responses — a real concern when incentivizing busy professionals.

Designing compliant pharma studies

Pharma research carries obligations that consumer research does not. A few principles for using AI interviews responsibly:

1. Keep it non-promotional. Use research to learn, not to detail. Frame concepts and educational materials neutrally and avoid leading questions — Koji's probing is designed to follow the respondent, not to steer.
2. Plan for adverse event (AE) handling. Any research touching marketed products needs an AE reporting process. Build a screening note and a clear escalation path into your study design, and brief your pharmacovigilance team before fielding.
3. Minimize and protect personal data. Use structured questions and screeners to collect only what the study needs. Koji encrypts data in transit (TLS 1.2+) and at rest (AES-256), offers a DPA, and supports anonymization workflows — important when handling HCP or patient information. For regulated patient data, review the HIPAA and GDPR guidance below.
4. Capture consent in the flow. Because Koji interviews are link-based and asynchronous, consent and study information can be presented at the start of the interview, creating a clean, auditable trail.
5. Document your methodology. Koji's research brief becomes your study documentation — the questions, the audience, and the analysis approach in one place.

A practical example

Suppose a biotech team wants to understand why oncologists hesitate to adopt a newly approved therapy. With Koji they would:

• Write a brief targeting practicing oncologists, with open-ended questions on adoption barriers plus a scale question on likelihood to prescribe and a ranking question on decision factors (efficacy, safety, cost, guidelines).
• Share a personalized interview link with a recruited HCP panel.
• Let Koji conduct voice interviews and probe every hesitation automatically.
• Read a real-time report that quantifies the ranking, charts the likelihood scale, and clusters the open-ended barriers into themes with supporting quotes.

What used to be a six-week moderated study becomes a few days of fielding and same-day synthesis.

Getting started

Start with one high-stakes question — an adoption barrier, a patient adherence gap, or a positioning test — and design a short study around it. Use a tight screener to reach the right audience, lean on structured questions for the metrics you need to track over time, and let open-ended questions plus AI probing surface the why. Bring your compliance and pharmacovigilance teams in early, and you will have a repeatable, defensible, and dramatically faster research engine.

Common pitfalls to avoid

Life sciences teams new to AI interviews tend to stumble on the same few issues — all avoidable with planning:

• Treating it like a survey. The value of an interview is the follow-up. Write fewer, deeper open-ended questions and let Koji probe, rather than porting a 30-item survey into an interview format.
• Skipping the screener. Reaching the wrong specialty or patient cohort wastes the study. Use a tight screener so every completed interview is in-segment.
• Forgetting longitudinal value. Reuse the same structured scale questions across studies so likelihood-to-prescribe, satisfaction, or adherence become trackable over time, not one-off readings.
• Underestimating compliance lead time. Loop in compliance and pharmacovigilance before fielding, not after, so adverse event handling and consent language are settled up front.
• Over-collecting personal data. Gather only what the research question requires; minimization is both a compliance win and a trust signal to respondents.

Avoiding these keeps studies fast, defensible, and genuinely insightful — the combination that makes AI interviews a durable part of the life sciences research toolkit rather than a one-time experiment.

Related Resources

• Structured Questions Guide — the six question types for mixed-methods pharma studies
• AI Research for Healthcare — adjacent guidance for care delivery and health systems
• HIPAA-Compliant AI User Research — handling regulated patient data
• GDPR-Compliant AI User Research — research under GDPR
• Concept Testing Guide — testing educational concepts and positioning
• Generating Research Reports — turning interviews into analysis-ready reports